top of page

CloudMD: The Future of Telemedicine

  • Writer: SmallCapInvestor
    SmallCapInvestor
  • Aug 9, 2020
  • 4 min read

Updated: Apr 14, 2023


Since the start of the COVID-19 pandemic, the demand for telehealth and virtual doctors appointments in North America has grown rapidly as more patients seek medical treatment while reducing the need for physical contact. The telemedicine sector might be hot but it still remains a largely untapped market and we believe it will stay strong for years to come. Similar to WELL Health Technologies, one of our previous picks, CloudMD is also leveraging the power of technology to enhance the overall medical clinic experience. Their goal is to create a comprehensive, streamlined one-stop shop for patients seeking medical care. With a strong cash position, CloudMD is well positioned to capture a portion of this largely untapped market by executing on their inorganic growth strategy (growth through acquisitions).

What does CloudMD do?

CloudMD offers SaaS based health technology solutions to medical clinics and healthcare providers across North America. They have developed proprietary technology that delivers quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). CloudMD’s integrated telehealth technology is used in the medical clinic practice to provide patient centric, continuity of care. CloudMD currently provides service to a combined ecosystem of 376 clinics, over 3000 licensed practitioners and almost 3 million patient charts across its servers.

Recent Acquisitions


On August 6, 2020, CloudMD announced it has entered into a binding agreement to acquire 100% of a U.S. based medical clinic serving chronic care patients as a part of its broader strategy for entering the U.S. market with its comprehensive suite of telehealth products. The acquisition is an important and strategic part of CloudMD’s cross-border expansion plan into the United States and also distinguishes it from its main competitor WELL Health Technologies. The opportunity for expansion here is huge, as in the U.S alone, 90% of the $3.5 Trillion spent annually on health care is spent on chronic pain and mental health issues.


On July 28, 2020, CloudMD announced signing a definitive agreement to acquire South Surrey Medical Clinic, a premier provider of integrated medical solutions and an early adopter of telemedicine delivery. The Clinic has been able to streamline healthcare services and provide longitudinal and team-based patient centric care by offering a number of medical services from one location. South Surrey services over 60,000 patients and already uses online booking, EMR software and telemedicine that will be easily integrated into CloudMD’s software and clinic network.


We believe that these acquisitions are a step in the right direction for CloudMD as they will enable to the company to vertically integrate their technology into brick and mortar medical clinics. This is in line with their goal of creating a single comprehensive stop for longitudinal healthcare for chronic and complex care patients in North America. We believe that the synergies of this acquisition can be realized immediately, with CloudMD’s software being easily integrated into the brick and mortar clinic model to effectively enhance efficiency and profitability. The acquisition also proves that CloudMD is committed to executing on their inorganic growth strategy. Moving forward, with over $16 million cash, we believe the company will continue to acquire clinics and digital assets to add to their existing portfolio.

Relative Undervaluation

A compelling case for an investment into CloudMD is also supported by a relative undervaluation to its peer group. It is interesting to note that the peer group is very limited because there are so few companies operating in the space.

At present, CloudMD is being too heavily undervalued by the market based on a comparable analysis using EV/SALES(’21) as the primary metric.


From the table above, we can see that the enterprise value for CloudMD is around $92 million while the consensus estimate for 2021 revenue is $34.7million. So, EV/SALES(’21) = 2.6x. This is incredibly low, especially when compared with other companies in the peer group. WELL is currently trading at 9.8x EV/Sales(’21). TelaDoc is currently trading at 11.8x EV/Sales(’21). The peer group average is 8.1x. If we were to apply the industry average EV/SALES of 8.1x to CloudMD’s expected revenue in 2021, then CloudMD should be valued at around $280million CAD or $2.47 per share. It is our opinion that this value gap will start to close as CloudMD continues to acquire additional clinics and technology-related assets and capture a larger portion of the North American telehealth market.

A Technical Analysis Perspective


Now let’s take a look at the chart to see if we can try to predict where the stock might be headed next. Since we have a medium-term time horizon on CloudMD, we will use a 3-month chart.

The first thing we noticed is that from July to August, CloudMD’s stock was stuck in a downtrend. However, at the beginning of August, a wave of buying triggered a breakout past the resistance level, signalling a bullish reversal in the trend for the medium to long term.


Probably the most important aspect of this chart is the “gap” from $0.69 to $0.72.


Why are “gaps” useful? Because historical data shows that when a stock price gap is observed, there is a chance of 91.4% that it will get filled in the future. In layman's word, 9 in 10 gaps get filled; not always, but pretty close.


Looking at more recent trading history, we can see that the newly established support level is at $0.85.


We see two possible scenarios playing out here. Either way, what is important to keep in mind is that the long term trend has REVERSED and we expect this uptrend to continue over the medium to long term.


Scenario A: the stock bounces off the support level at $0.85 and immediately continues the upward trend.


Scenario B: the support level breaks down and the gap which we previously referred to will get filled. If this does happen, this is when the most opportune time to buy would be. As there is an earnings call on August 27th which should act as a catalyst for movement in the stock price.

Our Price Target

Being an early mover in the largely untapped telehealth sector, CloudMD should be able to capture a significant share of the market via its cash position and inorganic growth strategy. We believe that over the long term CloudMD’s stock price will converge with its relative valuation of $2.47 per share, offering +174.4% upside from current prices.

 
 
JSC LOGO BLACK BARS PNG.png

CONTACT US

E-mail:

Social:

  • Twitter
  • Discord
  • Whatsapp
  • YouTube
  • Instagram

SUBSCRIBE NOW

You are now subscribed to SmallCapInvestor.ca

DISCLAIMER

This is the official website of SmallCapInvestor (“SmallCapInvestor” or the “Creator”).

Please read the following terms and conditions of website use (the “terms and conditions”) carefully before accessing or using the Creator’s website as they represent a binding agreement between you (either an individual or a single entity) and the Creator and govern your use of www.smallcapinvestor.ca together with all of the information and materials available on such website (collectively, “This Site” or “www.smallcapinvestor.ca”). By accessing, browsing or using This Site, you agree to be bound by the terms and conditions as outlined herein. If you have not read, do not understand, or do not agree to be bound by these terms and conditions, please do not use This Site. The Creator reserves the right to change these terms and conditions from time to time at its sole discretion and without notice.

It is your responsibility to check for any updates, and you should revisit this page from time to time as your use of This Site is subject to the most current version of the terms and conditions posted at the time of such use.

The Creator has taken all reasonable care in producing and publishing information contained on This Site and will endeavour to do so regularly. However, material on This Site may still contain technical or other inaccuracies, omissions, or typographical errors, for which the Creator assumes no responsibility. Under no circumstances shall the Creator be liable for any direct, indirect, special, incidental, consequential or other damages, including but not limited to, loss of programs, loss of data, loss of use of computer or other systems, or loss of profits, whether or not advised of the possibility of damage arising from your use, or inability to use, the material on This Site. Further, you may not modify or reproduce in any form, electronic or otherwise, any information on This Site.

Your rights to use This Site

Provided that you accept and comply with these terms and conditions, you have the limited right to access and use This Site to view the various materials, including information, documents and other content on This Site and to copy, download or print a single copy of any of the information and materials available on it, solely for your personal non-commercial use or your internal informational use in business and not for resale or distribution to anyone else, provided that you reproduce all of the Creator’s proprietary markings on each copy of reproduced material. Except as expressly permitted by the Creator in writing, you may not copy, reproduce, download, upload, post, transmit, translate, modify, distribute, sell, rent, license, transfer, mirror, frame or create derivative works from This Site, in whole or in part, in any form or by any means. 

Do Not Use Any Information in Our Publications to Make an Investment Decision

We are paid advertisers and we are publishers of publicly disseminated information on behalf of our clients, publicly traded companies, or non-affiliate third party shareholders of various issuers (“Client Companies”). Do not base an investment decision on any of the contents of our publications on This Site.

We are not registered as and we do not act, directly or indirectly, in the capacity of any of the following and you should not construe our activities as involving advice from any of the following: (a) an investment advisor; (b) a broker dealer; (c) a broker; (d) a dealer; (e) a stock recommender; (f) a stock picker; (g) a finder; (h) a securities trading expert; (i) a financial planner; (j) a securities analyst; or (k) a financial analyst.

The information found on This Site was prepared without regard to any particular investor’s investment objectives, financial situation, or financial or investment needs. Accordingly, investors should not act on any information contained on This Site without obtaining specific advice from their financial advisors and should not rely on information herein as the basis for their investment decisions. Investments based on the information provided on www.smallcapinvestor.cainvolve a substantial risk of loss and are not appropriate for everyone. No representation is being made that utilizing the information on www.smallcapinvestor.ca will result in profitable trading or be free of risk of loss. Before deciding to trade or invest you should carefully consider your investment objectives, level of experience, and ability to tolerate risk. The possibility exists that you could sustain a loss of some or all of your investment. 

Forward-Looking Information

Certain information contained on www.smallcapinvestor.ca, including any information as to the future financial or operating performance of the Client Companies highlighted, may be deemed “forward looking”. All statements on www.smallcapinvestor.ca, other than statements of historical fact, which address events or developments is expected to occur, are “forward-looking statements” or “forward-looking information”. Generally, these forward-looking statements can be identified by the use of forward-looking terminology, including but not limited to, the words “expects”, “does not expect”, “plans”, “anticipates”, “does not anticipate”, “believes”, “intends”, “estimates”, “projects”, “potential”, “scheduled”, “forecast”, “budget” and similar expressions or their negative connotations, or that events or conditions “will”, “would”, “may”, “could”, “should” or “might” occur. 

All such forward-looking statements are subject to important risk factors and uncertainties, many of which are beyond the ability to control or predict. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause Client Companies’ actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements.

Forward-looking statements are not guarantees of future performance, and actual results and future events could materially differ from those anticipated in such statements. All of the forward-looking statements contained on www.smallcapinvestor.ca are qualified by these cautionary statements. The Creator expressly disclaims any intent or obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise, except in accordance with applicable securities laws.

Indemnity

To the maximum extent permitted by applicable law, you will defend, indemnify and hold harmless the Creator, and its respective directors, officers, employees, consultants and agents from and against all claims, liability, and expenses, including all legal fees and costs, arising out of your breach of any provision of these terms and conditions or, any applicable law or proprietary or privacy right in connection therewith. The Creator reserves the right, in its sole discretion and at its own expense, to assume the exclusive defence and control of any matter otherwise subject to indemnification by you. You will co-operate as fully as reasonably required in the defence of any claim.

Stock Quotes

All stock price quotes and historical stock price data on This Site are provided by third parties, are for informational purposes only, and are not intended for trading purposes. If you are contemplating trading in securities of companies mentioned on www.smallcapinvestor.ca, the Creator strongly advises that you obtain independent professional advice (including independent legal and financial advice from qualified advisors) before making any investment decision. The Creator makes no representation or warranty regarding the timeliness, accuracy or completeness of any stock price quotes or historical stock price data.

Laws

This Site (excluding linked sites) is controlled by the Creator from its offices within the Province of British Columbia, Canada. By accessing This Site, you and the Creator agree that all matters relating to your access to, or use of, This Site shall be governed by the statutes and laws of the Province of British Columbia or the federal laws of Canada, as applicable, without regard to the conflicts of laws principles thereof. You and the Creator also agree and hereby submit to the exclusive personal jurisdiction and venue of the courts of the Province of British Columbia with respect to any and all matters arising in connection with these terms and conditions. 

Third Party Links 

The Creator has provided links from This Site to several other websites (“Third Party Websites”) that are arm’s-length to the Creator, and may embed content from Third Party Websites on This Site. The viewer should be aware that in linking to Third Party Websites they are leaving This Site and the Creator is not responsible for the content of any Third Party Website. Information on Third Party Websites, and any information from Third party Websites embedded on This Site, may be updated, revised, or otherwise modified without the knowledge or involvement of the Creator.  The Creator expressly disclaims any and all responsible for the accuracy of the content on any Third Party Websites, whether on This Site or not. 

bottom of page